PAPER Stella F, Radanovic M, Aprahamian I, Canineu PR, de Andrade LP, Forlenza OV
SEARCH RESULTS
330988 RESULTS
PAPER Romero JP, Benito-León J, Mitchell AJ, Trincado R, Bermejo-Pareja F
Under reporting of dementia deaths on death certificates using data from a population-based study (NEDICES).
J Alzheimers Dis. 2014;39(4):741-8. PubMed: 24254704PAPER Palavicini JP, Wang H, Minond D, Bianchi E, Xu S, Lakshmana MK
RanBP9 overexpression down-regulates phospho-cofilin, causes early synaptic deficits and impaired learning, and accelerates accumulation of amyloid plaques in the mouse brain.
J Alzheimers Dis. 2014;39(4):727-40. PubMed: 24254706PAPER Lee HR, Shin HK, Park SY, Kim HY, Lee WS, Rhim BY, Hong KW, Kim CD
Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: targeting for cilostazol.
J Neurosci Res. 2014 Feb;92(2):206-17. Epub 2013 Nov 19 PubMed: 24254769PAPER Reynolds A
Alzheimer disease: focus on computed tomography.
Radiol Technol. 2013 Nov-Dec;85(2):187CT-211CT. PubMed: 24255154PAPER Louis ED, Galecki M, Rao AK
Four Essential Tremor Cases with Moderately Impaired Gait: How Impaired can Gait be in this Disease?
Tremor Other Hyperkinet Mov (N Y). 2013;3 Epub 2013 Nov 4 PubMed: 24255798PAPER Chiu M, Wesson V, Sadavoy J
Improving caregiving competence, stress coping, and mental well-being in informal dementia carers.
World J Psychiatry. 2013 Sep 22;3(3):65-73. PubMed: 24255878T. Christopher Gamblin on ‘Godfather of Tau’ Skip Binder Dies at 63
COMMENT I was a postdoc in Skip’s lab at Northwestern from 1998-2002 and we were good friends and colleagues after that. Skip was incredibly generous with his time and friendship. He was always there for people, no matter what. His passing makes one realize just
T. Christopher Gamblin
University of KansasUnited States
Kenneth Kosik on ‘Godfather of Tau’ Skip Binder Dies at 63
COMMENT Irreverent, witty, lively, and always full of kindness and generosity, Skip’s untimely death must give pause to all of us who knew him, and many more who only knew of him. We should build upon his insights as we delve ever more deeply into the diseases th
PAPER Citrome L
A review of the pharmacology, efficacy and tolerability of recently approved and upcoming oral antipsychotics: an evidence-based medicine approach.
CNS Drugs. 2013 Nov;27(11):879-911. PubMed: 24062193PAPER Giaccone G, Giaccone G, DiFede G, Giovagnoli AR, Tagliavini F
A novel missense mutation in Psen2 gene associated with a clinical phenotype of frontotemporal dementia
Alzheimers Dement. 2008;4(S2):T590PAPER Gallo M, Tomaino C, Bernardi L, Maletta R, Anfossi M, Geracitano S, Vasso F, Puccio G, Colao R, Frangipane G, Mirabelli M, Smirne N, Muraca MG, De Vito O, Bruni AC
PS1 polymporphism and a novel PS2 mutation in a patient with late-onset familial Alzheimer's disease
Alzheimers Dement. 2008;4(S2):T585PAPER Piscopo P, Talarico G, Spadoni O, Malvezzi-Campeggi L, Crestini A, Gasparini M, Vanacore N, Lenzi GL, Pocchiari M, Confaloni A, Bruno G
A novel Italian presenilin 2 mutation (S175Y)
Alzheimers Dement. 2008;4(S2):T595.PAPER Sorbi S, Tedde A, Nacmias B, Ciantelli M, Caffarra P, Ghidoni E, Bracco L, Piccini C
Novel presenilin 1 and presenilin 2 mutations in early-onset Alzheimer's disease families
Neurobiol Aging. 2002 Jul-Aug;23(1S):312.Current Filters
No filters selected